Advertisement



Articles prepublished December 21, 2011

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH10-03-0204
Issue:2010: 104/5 (Nov) pp. 863-1082
Pages:1078-1079

Issue
Article

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

M. M. Samama (1, 2), J. Amiral (3), C. Guinet (2), E. Perzborn (4), F. Depasse (2)

(1) Hôtel-Dieu University Hospital, Paris, France; (2) Biomnis Laboratories R&D, Ivry sur Seine, France; (3) HyphenBiomed, Neuville sur Oise, France; (4) Bayer HealthCare AG, Wuppertal, Germany

DOI

http://dx.doi.org/10.1160/TH10-03-0204
[PDF] [Pay per view] [Remove from basket]

Articles

You've 119 Article(s) in your Basket.

Thrombosis News

TH107.2

With the expiry or pending expiry of originator low-molecular-weight heparin (LMWH) patents,...

TH 107.1

T&H has a new type of article! Read the first T&H Insights article by Lutgens et al. in the...

TH Index

The Index for volume 106 of Thrombosis and Haemostasis is now available online. Click here.